Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
5
×
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biogen
cancer
deals
eli lilly
medicare
pfizer
bristol-myers squibb
clinical trials
drug prices
What
bio
5
×
drug
5
×
roundup
5
×
companies
alzheimer’s
nash
news
price
prices
acquisitions
albert
annual
approval
approved
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
bourla
ceo
communities
company
conference
convo
crispr
different
digital
disease
earlier
epidemic
esmo
europe
fail
failures
fatty
fda
frenzied
future
Language
unknown
Current search:
roundup
×
bio
×
" detroit blog main "
×
" cancer immunotherapy "
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More